Detection of renal allograft dysfunction with characteristic protein fingerprint by serum proteomic analysis

International Urology and Nephrology

Volumn 43, Issue 4, 2011, Pages 1009-1017

  Wang, Minmin ^a   Jin, Qiu ^a   Tu, Haiyan ^a   Mao, Youying ^a,b   Yu, Jiekai ^a   Chen, Ying ^a,b   Shou, Zhangfei ^a,b,c   He, Qiang ^a,b,c   Wu, Jianyong ^a,b,c   Zheng, Shu ^a   Chen, Jianghua ^a,b,c  

^a ZHEJIANG UNIVERSITY   (China)

^b State Administration of Traditional Chinese Medicine   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

Acute rejection; Proteome; Renal allograft dysfunction; Surface enhanced laser desorption ionization time of flight mass spectrometry (SELDI TOF MS)

Indexed keywords

CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROTEOME; RAPAMYCIN; TACROLIMUS; BIOLOGICAL MARKER;

ADULT; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY TUBULE NECROSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEOMICS; RENAL GRAFT DYSFUNCTION; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; ANALYSIS OF VARIANCE; ASYMPTOMATIC DISEASE; BIOLOGY; BIOPSY; BLOOD; GRAFT REJECTION; KIDNEY TRANSPLANTATION; MASS SPECTROMETRY; MIDDLE AGED; PATHOLOGY; PEPTIDE MAPPING; PHYSIOLOGY; REPRODUCIBILITY;

ADULT; ANALYSIS OF VARIANCE; ASYMPTOMATIC DISEASES; BIOLOGICAL MARKERS; BIOPSY; COMPUTATIONAL BIOLOGY; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; KIDNEY TUBULAR NECROSIS, ACUTE; MALE; MIDDLE AGED; PEPTIDE MAPPING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; YOUNG ADULT;

EID: 84859927990     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-011-9962-5     Document Type: Article

References (32)

1. Nankivell BJ, Chapman JR (2006) Chronic allograft nephropathy: current concepts and future directions. Transplantation 815:643-654
2. Cornell LD, Colvin RB (2005) Chronic allograft nephropathy. Curr Opin Nephrol Hypertens 143:229-234
3. Schwarz A et al (2005) Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study. Kidney Int 671:341-348
4. Colvin RB (2003) Chronic allograft nephropathy. N Engl J Med 34924:2288-2290
5. Choi BS et al (2005) Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center. Am J Transplant 56:1354-1360
6. Shishido S et al (2003) The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol 144:1046-1052
7. Strom TB (2005) Rejection-more than the eye can see. N Engl J Med 35322:2394-2396
8. Jianghua C et al (2005) C4d as a significant predictor for humoral rejection in renal allografts. Clin Transplant 196:785-791
9. Chen JH, Wang RD, wu JY (2004) The impact of early vascular rejection on late rejection in 1062 cadaveric renal transplant. J Am Soc Nephrol 15:812
10. Wu JY et al (2004) Improved clinical outcomes in Chinese renal allograft recipients receiving lower dose immuno-suppressants. Transplantation 785:713-718
11. Muthukumar T et al (2005) Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 35322:2342-2351
12. Wittke S et al (2005) Detection of acute tubulointerstitial rejection by proteomic analysis ofurinary samples in renal transplant recipients. Am J Transplant 510:2479-2488
13. Flechner SM et al (2004) Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 49:1475-1489
14. Sarwal M et al (2003) Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med 3492:125-138
15. Rai AJ et al (2005) Analysis of human proteome organi-zation plasma proteome project (HUPO PPP) reference specimens using surface enhanced laser desorption/ioni-zation-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkers. Proteomics 513:3467-3474
16. Tolson J et al (2004) Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients. Lab Invest 847:845-856
17. Issaq HJ et al (2003) SELDI-TOF MS for diagnostic pro-teomics. Anal Chem 757:148A-155A
18. Fung E et al (2003) The use of SELDI ProteinChip array technology in renal disease research. Methods Mol Med 86:295-312
19. Xu WH et al (2006) Preoperatively molecular staging with CM10 ProteinChip and SELDI-TOF-MS for colorectal cancer patients. J Zhejiang Univ Sci B 73:235-240
20. Yu JK et al (2005) An integrated approach utilizing pro-teomics and bioinformatics to detect ovarian cancer. J Zhejiang Univ Sci B 64:227-231
21. Chen YD et al (2004) Artificial neural networks analysis of surface-enhanced laser desorption/ionization mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clin Cancer Res 1024:8380-8385
22. Mao Y et al (2008) Diagnosis of renal allograft subclinical rejection by urine protein fingerprint analysis. Transpl Immunol 183:255-259
23. Schaub S et al (2004) Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 151:219-227
24. O'Riordan E et al (2004) Bioinformatic analysis of the urine proteome of acute allograft rejection. J Am Soc Nephrol 1512:3240-3248
25. Racusen LC, Halloran PF, Solez K (2004) Banff 2003 meeting report: new diagnostic insights and standards. Am J Transplant 410:1562-1566
26. O'Riordan E, Goligorsky MS (2005) Emerging studies of the urinary proteome: the end of the beginning? Curr Opin Nephrol Hypertens 146:579-585
27. Clarke W et al (2003) Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg 2375: 660-664 discussion 664-665
28. Somorjai RL, Dolenko B, Baumgartner R (2003) Class prediction and discovery using gene microarray and pro-teomics mass spectroscopy data: curses, caveats, cautions. Bioinformatics 1912:1484-1491
29. Byvatov E, Schneider G (2003) Support vector machine applications in bioinformatics. Appl Bioinformatics 22: 67-77
30. Furey TS et al (2000) Support vector machine classifica-tion and validation of cancer tissue samples using micro-array expression data. Bioinformatics 1610:906-914
31. Wang JX et al (2006) Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma. Proteomics 619:5344-5349
32. Nankivell BJ et al (2003) The natural history of chronic allograft nephropathy. N Engl J Med 34924:2326-2333